SCHEMBL4727202

SCHEMBL4727202

O=C(O)C1CCCc2c1[nH]c1ccc(Cl)c(F)c21

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 15/20 0.53
SIRT2 Q8IXJ6 5/20 0.46
SIRT3 Q9NTG7 2/20 0.46
LMNA P02545 2/20 0.42
ALOX15 P16050 2/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.41
TSHR P16473 1/20 0.40
MAP2 P11137 1/20 0.40
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8223572 0.89 SIRT1 (0.60) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL4727105 0.89 SIRT1 (0.60) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL8221598 0.89 SIRT1 (0.60) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL4726198 0.87 SIRT1 (0.55) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL31328307 0.83 MEN1 (0.64) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL4780145 0.83 MEN1 (0.64) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL11736161 0.81 SIRT1 (0.60) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL1872729 0.77 SIRT1 (0.52) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL4779722 0.76 SIRT1 (0.62) SIRT1SIRT2SIRT3LMNAALOX15
SCHEMBL11738090 0.76 SIRT1 (0.51) SIRT1SIRT2SIRT3LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008019825-A1 USE OF TRICYCLIC INDOLE DERIVATIVES FOR THE TREATMENT OF MUSCULAR DISEASES SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2008-02-21 WO disclosed
WO-2008019825-A1 USE OF TRICYCLIC INDOLE DERIVATIVES FOR THE TREATMENT OF MUSCULAR DISEASES SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2008-02-21 WO disclosed